- Home
- OUST vs QDEL Comparison
OUST vs QDEL Comparison
Compare OUST & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OUST | QDEL |
|---|---|---|
| Founded | 2015 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.0B |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | OUST | QDEL |
|---|---|---|
| Price | $26.03 | $12.01 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 4 |
| Target Price | ★ $39.25 | $28.25 |
| AVG Volume (30 Days) | 1.8M | ★ 2.7M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | $33.20 | $3.51 |
| Revenue Next Year | $37.27 | $3.86 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.65 | $10.86 |
| 52 Week High | $41.65 | $37.24 |
Technical Indicators
Market Signals| Indicator | OUST | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 60.47 | 38.69 |
| Support Level | $21.03 | $10.86 |
| Resistance Level | $30.10 | $17.78 |
| Average True Range (ATR) | 1.89 | 1.12 |
| MACD | 0.13 | 0.04 |
| Stochastic Oscillator | 64.29 | 17.09 |
Price Performance
Historical ComparisonAbout OUST Ouster Inc.
Ouster Inc is a provider of lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries. Ouster's products include high-resolution scanning and solid-state digital lidar sensors, Velodyne Lidar sensors, and software solutions. The company operates in the Americas, Asia and Pacific, Europe, Middle East, and Africa regions. It derives maximum revenue from Americas.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.